Optimization of perioperative hemodynamics in cytoreductive surgery of ovarian cancer with malignant ascites

被引:0
作者
Yildiz, Gunes Ozlem [1 ]
Sertcakacilar, Gokhan [1 ]
Akyol, Duygu [2 ]
Karaka, Sema [3 ]
Hergunsel, Gulsum Oya [1 ]
机构
[1] Univ Hlth Sci Istanbul, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Anesthesiol & Intens Care, Istanbul, Turkey
[2] Basaksehir Cam & Sakura City Hosp, Dept Anesthesiol & Intens Care, Istanbul, Turkey
[3] Univ Hlth Sci Istanbul, Bakirkoy Dr Sadi Konuk Training & Res Hosp, Dept Gynecol Oncol, Istanbul, Turkey
来源
CUKUROVA MEDICAL JOURNAL | 2022年 / 47卷 / 03期
关键词
Epitelial ovarian cancer; fluid-therapy; hemodynamic monitoring; malignant ascites; SEPTIC SHOCK; NOREPINEPHRINE; MANAGEMENT; SOCIETY; STAGE; CARE;
D O I
10.17826/cumj.1097476
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: In this study, we aimed to evaluate the effects of norepinephrine and albumin use in patients with epithelial ovarian cancer with malignant ascite in order to maintain plasma oncotic pressure and intravascular volume, to provide perioperative hemodynamic stabilization and tissue perfusion. In addition, it was aimed to compare in terms of postoperative intensive care admission, hospital stay and complications. Materials and Methods: A total of 66 patients, 38 with ascites and 28 without ascites, who underwent cytoreductive surgery for ovarian cancer were included in this study. PVI and invasive arterial monitoring of the patients were performed after hemodynamic stabilization (after the start of surgery) (T-0). T-0, 1st hour (T1) and 2nd hour (T2) and postoperative (T-postop.) Ascites patients were composed of 3 subgroups which the ones received norepinephrine (NE) infusion, norepinephrine + albumin (NEA) infusion or only fluid therapy (FT). From the perioperative hemodynamic and laboratory data of the patients, tissue perfusion was evaluated with lactate, and hemodynamic status was evaluated with pleth variability index (PVI), perfusion index (PI) and mean arterial pressure (MAP). Results: Demographic and clinical findings did not differ significantly between patients with and without ascites. Lactate level in NEA / NE group in Tpostop, PVI level in T1h, T2h and T-postop time frames were determined higher than the FT group. PI was found to be significantly lower in the T2 time frame. The postoperative ICU admission rate was higher in the NEA and NE groups. The duration of ICU stay in group NEA was shorter than in group NE. Conclusions: We recommend the use of low-dose NE with albumin to provide perioperative hemodynamic optimization, tissue perfusion and plasma oncotic pressure in surgery of ovarian cancer with malignant ascites. Despite high fluid replacement in these patients, the use of norepinephrine and albumin together may have an important role in preventing / reducing major complications in the perioperative period.
引用
收藏
页码:950 / 960
页数:11
相关论文
共 50 条
  • [1] Hyperthermic Intraperitoneal Perfusion Chemotherapy and Cytoreductive Surgery for Controlling Malignant Ascites From Ovarian Cancer
    Ba, Mingchen
    Long, Hui
    Zhang, Xiangliang
    Tang, Yunqiang
    Wu, Yinbing
    Wang, Shuai
    Yan, Zhaofei
    Zhang, Bohuo
    Cui, Shuzhong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (09) : 1571 - 1579
  • [2] Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites
    Ba, Mingchen
    Long, Hui
    Zhang, Xiangliang
    Tang, Yunqiang
    Wu, Yinbing
    Yu, Feihong
    Wang, Shuai
    Cui, Shuzhong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (09) : 1497 - 1506
  • [3] Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites
    Mingchen Ba
    Hui Long
    Xiangliang Zhang
    Yunqiang Tang
    Yinbing Wu
    Feihong Yu
    Shuai Wang
    Shuzhong Cui
    Journal of Cancer Research and Clinical Oncology, 2014, 140 : 1497 - 1506
  • [4] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer
    Tentes, Antonios-Apostolos K.
    Korakianitis, Odysseas S.
    Kakolyris, Stylianos
    Kyziridis, Dimitrios
    Veliovits, Dousan
    Karagiozoglou, Chrysa
    Sgouridou, Evanthia
    Moustakas, Konstantinos
    TUMORI, 2010, 96 (03) : 411 - 416
  • [5] Cholecystectomy as Part of Cytoreductive Surgery for Advanced Ovarian Cancer: Perioperative Outcomes
    Liakou, Chrysoula G.
    Akrivos, Nikolaos
    Kumar, Bhaskar
    Duncan, Timothy J.
    Turnbull, Hilary L.
    Nieto, Joaquin J.
    Burbos, Nikolaos
    ANTICANCER RESEARCH, 2020, 40 (04) : 2331 - 2336
  • [6] Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer-a randomized study
    Ba, Mingchen
    Chen, Cheng
    Long, Hui
    Gong, Yuanfeng
    Wu, Yinbin
    Lin, Kunpeng
    Tu, Yinuo
    Zhang, Bohuo
    Wu, Wanbo
    MEDICINE, 2020, 99 (33) : E21546
  • [7] Ascites do not affect the rate of complete cytoreductive surgery and prognosis in patients with primary ovarian cancer with ascites treated with hyperthermic intraperitoneal chemotherapy
    Ba, Mingchen
    Long, Hui
    Zhang, Xiangliang
    Yan, Zhaofei
    Wang, Shuai
    Wu, Yinbing
    Gong, Yuanfeng
    Cui, Shuzhong
    ONCOLOGY LETTERS, 2019, 18 (02) : 2025 - 2033
  • [8] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer: 18 years of experience
    Liberis, Anastasios
    Kyziridis, Dimitrios
    Kalakonas, Apostolos
    Tentes, Antonios-Apostolos
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2024, 292 : 102 - 106
  • [9] Defining the limits of radical cytoreductive surgery for ovarian cancer
    Wright, Jason D.
    Lewin, Sharyn N.
    Deutsch, Israel
    Burke, William M.
    Sun, Xuming
    Neugut, Alfred I.
    Herzog, Thomas J.
    Hershman, Dawn L.
    GYNECOLOGIC ONCOLOGY, 2011, 123 (03) : 467 - 473
  • [10] Efficacy of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in the Management of Malignant Ascites
    Reese W. Randle
    Katrina R. Swett
    Douglas S. Swords
    Perry Shen
    John H. Stewart
    Edward A. Levine
    Konstantinos I. Votanopoulos
    Annals of Surgical Oncology, 2014, 21 : 1474 - 1479